You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,674,472


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,674,472
Title: Canisters containing aerosol formulations containing P134a and fluticasone propionate
Abstract:The present invention relates to canisters suitable for delivering a pharmaceutical aerosol formulation which comprises a container capable of withstanding the vapor pressure of the propellant used, which container is closed with a metering valve and contains a pharmaceutical aerosol formulation consisting essentially of a particulate medicament which is fluticasone propionate or a physiologically acceptable solvate thereof and 1,1,1,2-tetrafluoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based on the weight of the medicament, the particulate medicament being present in an amount from 0.005% to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 microns. A further particulate medicament may also be present in the pharmaceutical aerosol formulation.
Inventor(s): Akehurst; Rachel Ann (Ware, GB3), Taylor; Anthony James (Ware, GB3), Wyatt; David Andrew (Ware, GB3)
Assignee: Glaxo Group Limited (London, GB)
Application Number:08/444,919
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 5,674,472

Introduction

When delving into the specifics of a patent, understanding its scope and claims is crucial for inventors, researchers, and business professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 5,674,472, highlighting key aspects and implications.

Patent Overview

United States Patent 5,674,472 was granted on October 7, 1997. To analyze this patent, we need to consider several key components:

Patent Title and Abstract

The title and abstract provide the first glimpse into the invention's nature. While the specific title and abstract of US 5,674,472 are not provided here, these sections typically outline the main subject matter and the problem the invention solves.

Claims

Independent and Dependent Claims

Patent claims are the most critical part of a patent, as they define the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details.

  • Independent Claims: These claims should be broad enough to cover the core invention but not so broad that they encompass prior art or obvious variations.
  • Dependent Claims: These claims narrow down the invention, often adding specific features or limitations that differentiate the invention from prior art.

Claim Construction

Claim construction involves interpreting the language of the claims to determine their scope. This process is crucial for understanding what is protected by the patent and what might infringe on it.

Description and Drawings

The description and drawings provide detailed explanations of the invention, including how it works and its various components. These sections help in understanding the context and specifics of the claims.

Background of the Invention

This section explains the problem the invention addresses and the state of the art at the time of the invention. It sets the stage for why the invention is novel and non-obvious.

Detailed Description of the Invention

Here, the inventors describe the invention in detail, often with reference to the drawings. This section is vital for understanding how the invention works and its various embodiments.

Example Analysis

For a hypothetical example, let's consider a patent related to a medical device. The independent claims might define the overall structure and function of the device, while the dependent claims might specify materials, dimensions, or particular features.

Prior Art and Novelty

To understand the scope of the patent, it's essential to consider the prior art cited during the patent application process. Prior art includes all publicly available information that existed before the patent application was filed.

Common Citation Document (CCD)

Tools like the Common Citation Document (CCD) can help consolidate prior art citations from multiple patent offices, providing a comprehensive view of what was known before the invention[1].

Patent Landscape

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This helps in understanding how the patent fits into the broader global patent landscape[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal whether similar inventions have been patented abroad[1].

Patent Assignment and Ownership

Understanding who owns the patent and any changes in ownership is crucial for licensing, litigation, and other business decisions. The Patent Assignment Search website can be used to search for patent assignments and changes in ownership[1].

Economic and Statistical Analysis

For a deeper analysis, datasets like the Patent Claims Research Dataset provided by the USPTO can offer insights into patent scope and trends. This dataset includes detailed information on claims from US patents and applications, which can help in understanding the broader patent landscape and the economic impact of the patent[3].

Statistical Trends

Analyzing statistical trends from datasets can reveal patterns in patent filings, grant rates, and the scope of patents in specific industries. This information can be invaluable for strategic business decisions.

Practical Implications

Licensing and Collaboration

Understanding the scope and claims of a patent is essential for licensing agreements and collaborative research. It helps in determining what aspects of the invention can be licensed and under what terms.

Litigation

In the event of litigation, a clear understanding of the patent's scope and claims is critical. It helps in determining infringement and defending against infringement claims.

Key Takeaways

  • Claims Analysis: The claims are the heart of the patent and define its scope.
  • Prior Art: Understanding prior art is crucial for determining novelty and non-obviousness.
  • Global Landscape: The Global Dossier and international patent databases provide a comprehensive view of the patent's global standing.
  • Ownership: Tracking changes in ownership is vital for business decisions.
  • Economic Analysis: Statistical datasets can offer valuable insights into patent trends and economic impact.

FAQs

What is the importance of independent and dependent claims in a patent?

Independent claims define the broad scope of the invention, while dependent claims provide more specific details, narrowing down the invention.

How can I determine if my invention is novel and non-obvious?

By conducting a thorough search of prior art using tools like the Common Citation Document (CCD) and international patent databases.

What is the Global Dossier service, and how does it help in patent analysis?

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global patent family and related applications.

Where can I find detailed statistical data on patent claims and scope?

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications, offering insights into patent scope and trends.

Why is it important to track changes in patent ownership?

Tracking changes in ownership is crucial for licensing agreements, litigation, and other business decisions related to the patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - EP1575648A2: https://patents.google.com/patent/EP1575648A2
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - WO2004060260A2: https://patents.google.com/patent/WO2004060260A2
  5. Unified Patents Portal - US-7205343-B2: https://portal.unifiedpatents.com/patents/patent/US-7205343-B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,674,472

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,674,472

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9126378Dec 12, 1991
United Kingdom9126405Dec 12, 1991
United Kingdom9202522Feb 06, 1992

International Family Members for US Patent 5,674,472

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 402 ⤷  Subscribe
African Regional IP Organization (ARIPO) 9200461 ⤷  Subscribe
Austria 128350 ⤷  Subscribe
Austria 163539 ⤷  Subscribe
Austria 171865 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.